rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1998-6-4
|
pubmed:abstractText |
The clinical impact of endogenous cytokines supplied with deterministic properties in the generation of either T helper (Th)1 -type or Th2-type immune response was investigated in patients with ovarian cancer. Whereas interleukin (IL)- 12 initiates the differentiation of naive Th0 cells toward Th1 phenotype, IL-4 and IL-10 mediate the development of Th2-type immunity.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1861-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9586902-Adult,
pubmed-meshheading:9586902-Aged,
pubmed-meshheading:9586902-Ascitic Fluid,
pubmed-meshheading:9586902-Disease-Free Survival,
pubmed-meshheading:9586902-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:9586902-Female,
pubmed-meshheading:9586902-Humans,
pubmed-meshheading:9586902-Interleukin-10,
pubmed-meshheading:9586902-Interleukin-12,
pubmed-meshheading:9586902-Interleukin-4,
pubmed-meshheading:9586902-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:9586902-Middle Aged,
pubmed-meshheading:9586902-Neopterin,
pubmed-meshheading:9586902-Ovarian Neoplasms,
pubmed-meshheading:9586902-Prognosis,
pubmed-meshheading:9586902-Survival Rate,
pubmed-meshheading:9586902-Tumor Markers, Biological,
pubmed-meshheading:9586902-Tumor Necrosis Factor-alpha
|
pubmed:year |
1998
|
pubmed:articleTitle |
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University Hospital, University of Innsbruck, Austria. alain.zeimet@uibk.ac.at
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|